Czasopismo Clinical and Experimental Hepatology 2025

Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement

Jerzy Jaroszewicz, Marlena Broncel, Anna Piekarska, Filip M. Szymanski, Krzysztof Tomasiewicz, Paweł Rajewski, Maciej Banach, Bartosz Hudzik, Mariusz Gąsior, Robert Flisiak, Robert Gil

Clin Exp HEPATOL 2025; 11, 3: 205–218

DOI: https://doi.org/10.5114/ceh.2025.154978

Abstract Abstract (PDF)

Steatotic liver disease and chronic viral hepatitis

Jakub Janczura, Alessandra Mangia, Krystyna Dobrowolska, Michał Brzdęk, Kinga Brzdęk, Małgorzata Wajdowicz, Iwona Gorczyca-Głowacka, Piotr M. Stępień, Dorota Zarębska-Michaluk

Clin Exp HEPATOL 2025; 11, 3: 219–227

DOI: https://doi.org/10.5114/ceh.2025.154220

Abstract Abstract (PDF)

Implantation of nasobiliary drainage in treatment of severe episodes of benign recurrent intrahepatic cholestasis (BRIC) in pediatric patients

Maciej Dądalski, Tetiana Wojciechowska, Joanna Ryżko, Magda Naorniakowska, Joanna Cielecka-Kuszyk, Elżbieta Ciara, Małgorzata Sawilska-Tańska, Joanna Pawłowska

Clin Exp HEPATOL 2025; 11, 3: 228–231

DOI: https://doi.org/10.5114/ceh.2025.153806

Abstract Abstract (PDF)

Oral health-related quality of life and oral function in patients with metabolic dysfunction associated steatotic liver disease

Kouichi Miura, Naoshi Arai, Miki Ishikawa, Takako Yasuda, Nobue Wakabayashi, Aki Yamamoto, Yoshiyuki Mori, Kyoko Nakao, Hironori Yamamoto, Kazuhiko Kotani

Clin Exp HEPATOL 2025; 11, 3: 232–241

DOI: https://doi.org/10.5114/ceh.2025.154497

Abstract Abstract (PDF)

Three-year outcomes under pemafibrate therapy in patients with metabolic dysfunction-associated steatotic liver disease: a long-term observational study

Satoshi Shinozaki, Kouichi Miura, Toshiyuki Tahara, Nikolaos Lazaridis, Hironori Yamamoto

Clin Exp HEPATOL 2025; 11, 3: 242–248

DOI: https://doi.org/10.5114/ceh.2025.154217

Abstract Abstract (PDF)

Ethnic heterogeneity in steatosis-driven liver injury among MASLD patients: Han Chinese vs. Caucasian

Limin Lin, Junzhao Ye, Zhiyong Dong, Hong Deng, Yiyi Hu, Shiting Feng, Bing Liao, Xiaodong Zhuang, Bihui Zhong

Clin Exp HEPATOL 2025; 11, 3: 249–261

DOI: https://doi.org/10.5114/ceh.2025.154222

Abstract Abstract (PDF)

Profile of serum levels of TNF-a, IL-1b, IL-6, IL-8, IL-12, adiponectin, and vitamin D3 in male Polish patients with acute alcoholic hepatitis and alcoholic cirrhosis

Ryszard Tomasiuk, Magdalena Wiacek

Clin Exp HEPATOL 2025; 11, 3: 262–270

DOI: https://doi.org/10.5114/ceh.2025.153262

Abstract Abstract (PDF)

Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings

Ivana Hockicková, Ján Hockicko, Peter Jarčuška, Sylvia Dražilová, František Lami, Patrícia D. Lenártová, Pavol Mrážik, Adrián Gábor, Pavol Kristian

Clin Exp HEPATOL 2025; 11, 3: 271–278

DOI: https://doi.org/10.5114/ceh.2025.154078

Abstract Abstract (PDF)

The impact of acute CMV coinfection on the course of EBV hepatitis in children

Magdalena Rutkowska, Maria Pokorska-Śpiewak

Clin Exp HEPATOL 2025; 11, 3: 279–288

DOI: https://doi.org/10.5114/ceh.2025.154284

Abstract Abstract (PDF)

Does thyroid function disorder play a vital role in the pathogenesis of neonatal cholestasis?

Salma Abdel Megeed Nagi, Mai Ibrahim Elashmawy, Mohamed Zaeim Hafez Ahmed, Mahmoud Ahmad Mohammed Azab, Ashraf AbdelAty Elshenawy Emara, Osama Mohammad Mohammad Abdelhay, Mohamed AbdelAziz Doma, Ahmad Mohamed Mohamed Awad, Ahmed Mohammed Saba, Tarek Shikhon, Hesham Abdelrahman Mahmoud Ahmed, Ahmed Mohamed Gad Allah, Marwa Fekry Hassan, Shymaa Sobhy Menshawy Khalifa

Clin Exp HEPATOL 2025; 11, 3: 289–299

DOI: https://doi.org/10.5114/ceh.2025.154503

Abstract Abstract (PDF)

Efficacy of zinc and lactulose vs. lactulose monotherapy in improving cognitive function and serum ammonia levels in cirrhotic patients with minimal hepatic encephalopathy

Majid Almansouri, Ragdah H. Arif, Ahmad Fallatah, Iman Mirza, Afaf Albalawi, Waleed Badoghaish, Eyad Faizo, Dahlia S Mirdad, Humaira Waseem, Amber Hassan

Clin Exp HEPATOL 2025; 11, 3: 300–306

DOI: https://doi.org/10.5114/ceh.2025.154666

Abstract View text

Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement

Steatotic liver disease and chronic viral hepatitis

Implantation of nasobiliary drainage in treatment of severe episodes of benign recurrent intrahepatic cholestasis (BRIC) in pediatric patients

Oral health-related quality of life and oral function in patients with metabolic dysfunction associated steatotic liver disease

Three-year outcomes under pemafibrate therapy in patients with metabolic dysfunction-associated steatotic liver disease: a long-term observational study

Ethnic heterogeneity in steatosis-driven liver injury among MASLD patients: Han Chinese vs. Caucasian

Profile of serum levels of TNF-a, IL-1b, IL-6, IL-8, IL-12, adiponectin, and vitamin D3 in male Polish patients with acute alcoholic hepatitis and alcoholic cirrhosis

Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings

The impact of acute CMV coinfection on the course of EBV hepatitis in children

Does thyroid function disorder play a vital role in the pathogenesis of neonatal cholestasis?

Efficacy of zinc and lactulose vs. lactulose monotherapy in improving cognitive function and serum ammonia levels in cirrhotic patients with minimal hepatic encephalopathy

Coverage in

Integrated with

Editorial Policies